Anesiva Inc. began a Phase III trial to evaluate the ability of Zingo to provide pain relief to those undergoing peripheral venous access procedures, such as intravenous line placements and blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback